AUTHOR=Al-Amin Md. Mamun , Chowdury Md. Irfan Amin , Saifullah A. R. M. , Alam Mohammed Nazmul , Jain Preeti , Hossain Murad , Alam Md. Ashraful , Kazi Mohsin , Ahmad Ajaz , Raish Mohammad , Alqahtani Abdulmohsen , Reza Hasan Mahmud 

TITLE=Levocarnitine Improves AlCl3-Induced Spatial Working Memory Impairment in Swiss albino Mice

JOURNAL=Frontiers in Neuroscience

VOLUME=13

YEAR=2019

URL=https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2019.00278

DOI=10.3389/fnins.2019.00278

ISSN=1662-453X

ABSTRACT=<p><bold>Background:</bold> Aluminum, a neurotoxic substance, causes oxidative stress induced-neurodegenerative diseases. Several lines of evidence suggest that levocarnitine has an antioxidant effect and also plays an important role in beta-oxidation of fatty acids. However, the role of levocarnitine in aluminum-induced neurotoxicity has not been well documented. Here we aimed to investigate the effect of levocarnitine on aluminum chloride (AlCl<sub>3</sub>)-induced oxidative stress and memory dysfunction.</p><p><bold>Methods:</bold> Male <italic>Swiss albino</italic> mice (<italic>n</italic> = 30) were treated with either control (saline) or AlCl<sub>3</sub> or AlCl<sub>3</sub> plus levocarnitine or levocarnitine or astaxanthin plus AlCl<sub>3</sub> or astaxanthin alone. The spatial working memory was determined by radial arm maze (RAM). In addition, we measured the lipid peroxidation (MDA), glutathione (GSH), advanced oxidation of protein products (AOPP), nitric oxide (NO) and activity of superoxide dismutase (SOD) in the various brain regions including prefrontal cortex (PFC), striatum (ST), parietal cortex (PC), hippocampus (HIP) hypothalamus (HT) and cerebellum (CB). We used astaxanthin as a standard antioxidant to compare the antioxidant activity of levocarnitine.</p><p><bold>Results:</bold> The RAM data showed that AlCl<sub>3</sub> treatment (50 mg/kg) for 2 weeks resulted in a significant deficit in spatial learning in mice. Moreover, aluminum exposure significantly (<italic>p</italic> &lt; 0.05) increased the level of oxidative stress markers such as MDA, GSH, AOPP and NO in the various brain regions compared to the controls. In addition, combined administration of levocarnitine and AlCl<sub>3</sub> significantly (<italic>p</italic> &lt; 0.05) lowered the MDA, AOPP, GSH and NO levels in mice.</p><p><bold>Conclusion:</bold> Our results demonstrate that levocarnitine could serve as a potential therapeutic agent in the treatment of oxidative stress associated diseases as well as in memory impairment.</p>